Auspex inks deal with Teva for deuterium-containing drug
Auspex is a clinical stage biotechnology company focused on the discovery and development of novel therapeutics based on site-specific deuteration of promising drug candidates and clinically validated drugs.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.